These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 35011295)

  • 1. Anti-Inflammatory Activity of a CB2 Selective Cannabinoid Receptor Agonist: Signaling and Cytokines Release in Blood Mononuclear Cells.
    Capozzi A; Caissutti D; Mattei V; Gado F; Martellucci S; Longo A; Recalchi S; Manganelli V; Riitano G; Garofalo T; Sorice M; Manera C; Misasi R
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid CB
    Olianas MC; Dedoni S; Onali P
    Life Sci; 2021 Jul; 276():119407. PubMed ID: 33794254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, in vitro and in vivo evaluation of 1,3,5-triazines as cannabinoid CB2 receptor agonists.
    Yrjölä S; Sarparanta M; Airaksinen AJ; Hytti M; Kauppinen A; Pasonen-Seppänen S; Adinolfi B; Nieri P; Manera C; Keinänen O; Poso A; Nevalainen TJ; Parkkari T
    Eur J Pharm Sci; 2015 Jan; 67():85-96. PubMed ID: 25447744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective Cannabinoid 2 Receptor Agonists as Potential Therapeutic Drugs for the Treatment of Endotoxin-Induced Uveitis.
    Porter RF; Szczesniak AM; Toguri JT; Gebremeskel S; Johnston B; Lehmann C; Fingerle J; Rothenhäusler B; Perret C; Rogers-Evans M; Kimbara A; Nettekoven M; Guba W; Grether U; Ullmer C; Kelly MEM
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31540271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Proliferative Properties and Proapoptotic Function of New CB2 Selective Cannabinoid Receptor Agonist in Jurkat Leukemia Cells.
    Capozzi A; Mattei V; Martellucci S; Manganelli V; Saccomanni G; Garofalo T; Sorice M; Manera C; Misasi R
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29973514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the CB
    Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
    BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Novel Cannabinoid CB2 Receptor Agonists from Botanical Compounds and Preliminary Evaluation of Their Anti-Osteoporotic Effects.
    Hu SJ; Cheng G; Zhou H; Zhang Q; Zhang QL; Wang Y; Shen Y; Lian CX; Ma XQ; Zhang QY; Qin LP
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35163968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid CB2 receptor (CB2R) stimulation delays rubrospinal mitochondrial-dependent degeneration and improves functional recovery after spinal cord hemisection by ERK1/2 inactivation.
    Latini L; Bisicchia E; Sasso V; Chiurchiù V; Cavallucci V; Molinari M; Maccarrone M; Viscomi MT
    Cell Death Dis; 2014 Sep; 5(9):e1404. PubMed ID: 25188514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-based virtual screening identifies a family of selective cannabinoid receptor 2 agonists.
    Gianella-Borradori M; Christou I; Bataille CJ; Cross RL; Wynne GM; Greaves DR; Russell AJ
    Bioorg Med Chem; 2015 Jan; 23(1):241-63. PubMed ID: 25487422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent T cell-mediated anti-inflammatory role of the selective CB2 agonist lenabasum in multiple sclerosis.
    Tiberi M; Evron T; Saracini S; Boffa L; Mercuri NB; Chintalacharuvu SR; Atamas SP; Chiurchiù V
    Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12768. PubMed ID: 34543449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid receptor type 2 activation induces a microglial anti-inflammatory phenotype and reduces migration via MKP induction and ERK dephosphorylation.
    Romero-Sandoval EA; Horvath R; Landry RP; DeLeo JA
    Mol Pain; 2009 May; 5():25. PubMed ID: 19476641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory and antinociceptive effects of the selective cannabinoid CB
    Tang Y; Wolk B; Britch SC; Craft RM; Kendall DA
    J Pharmacol Sci; 2021 Apr; 145(4):319-326. PubMed ID: 33712283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile.
    Gómez-Cañas M; Morales P; García-Toscano L; Navarrete C; Muñoz E; Jagerovic N; Fernández-Ruiz J; García-Arencibia M; Pazos MR
    Pharmacol Res; 2016 Aug; 110():205-215. PubMed ID: 27013280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5-HT(2A)) receptor activity via ERK1/2 signaling.
    Franklin JM; Carrasco GA
    Synapse; 2013 Mar; 67(3):145-59. PubMed ID: 23151877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of cannabinoid CB
    Salort G; Álvaro-Bartolomé M; García-Sevilla JA
    Psychopharmacology (Berl); 2017 Mar; 234(6):925-941. PubMed ID: 28127623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent immunomodulatory activity of a highly selective cannabinoid CB2 agonist on immune cells from healthy subjects and patients with multiple sclerosis.
    Annunziata P; Cioni C; Mugnaini C; Corelli F
    J Neuroimmunol; 2017 Feb; 303():66-74. PubMed ID: 28041663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of ERK1/2, cPLA2 and NF-κB in microglia suppression by cannabinoid receptor agonists and antagonists.
    Ribeiro R; Wen J; Li S; Zhang Y
    Prostaglandins Other Lipid Mediat; 2013 Jan; 100-101():1-14. PubMed ID: 23219970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protective effect of cannabinoid type II receptor agonist AM1241 on ConA-induced liver injury in mice via mitogen-activated protein kinase signalling pathway.
    Wu Y; Ma R; Long C; Shu Y; He P; Zhou Y; Xiang Y; Wang Y
    Int J Immunopathol Pharmacol; 2021; 35():20587384211035251. PubMed ID: 34384259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain Natriuretic Peptide-Regulated Expression of Inflammatory Cytokines in Lipopolysaccharide (LPS)-Activated Macrophages via NF-κB and Mitogen Activated Protein Kinase (MAPK) Pathways.
    Li X; Peng H; Wu J; Xu Y
    Med Sci Monit; 2018 May; 24():3119-3126. PubMed ID: 29754152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propofol Inhibits Lipopolysaccharide-Induced Inflammatory Responses in Spinal Astrocytes via the Toll-Like Receptor 4/MyD88-Dependent Nuclear Factor-κB, Extracellular Signal-Regulated Protein Kinases1/2, and p38 Mitogen-Activated Protein Kinase Pathways.
    Zhou CH; Zhu YZ; Zhao PP; Xu CM; Zhang MX; Huang H; Li J; Liu L; Wu YQ
    Anesth Analg; 2015 Jun; 120(6):1361-8. PubMed ID: 25695672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.